TELL ME MORE
ABOUT THIS CLINICAL TRIAL for MIGRAINES in CHILDREN
This is an Double Blind, Placebo Controlled Phase 3 Study of an Investigational Medicine for Migraine Patients Ages 6 – 17 Years.
Clinical Trial for Migraines in Children
Study Location(s): Owensboro and Bowling Green Kentucky, Evansville Indiana
Migraine is one of the most common neurological conditions in pediatrics with a prevalence of approximately 8% in children under 20 years of age. Migraine occurs more frequently in adolescents compared with the younger pediatric age groups. There is a significant increase in migraine incidence in females after puberty. In children and adolescents, headache and migraine can result in missed school days, poorer academic performance and a negative impact on quality of life. There are few treatments approved for the acute treatment of migraine in adolescents, and only 1 treatment approved for children aged 6 to 11 years. Thus, there remains a significant unmet need for the acute treatment of migraine in children and adolescents. This is a double-blind, placebo-controlled, phase 3 study of an investigational medicine for acute migraine in children ages 6 – 17. Patient volunteers will have an option to enter a 52 week long-term open-label extension study. Click here for more information on living with pediatric migraine.
There is no cost to participate. Volunteers receive free investigational medicine and follow-up care. No insurance needed. Time and travel reimbursement up to $550 may be available.
Watch a short presentation on Migraines